Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy

Ophthalmology

Volumn 121, Issue 5, 2014, Pages 1073-1078

  Lim, Jennifer I ^a   Glassman, Adam R ^a   Aiello, Lloyd Paul ^a   Chakravarthy, Usha ^a   Flaxel, Christina J ^a   Spaide, Richard F ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; AGE; ANGIOGRAPHY; ARTICLE; CENTRAL SEROUS RETINOPATHY; CHRONIC DISEASE; CORTICOSTEROID THERAPY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RACE; RETINA DETACHMENT; RETROSPECTIVE STUDY; SUBRETINAL FLUID; VISUAL ACUITY;

CENTRAL SEROUS CHORIORETINOPATHY; CHRONIC DISEASE; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; REFRACTION, OCULAR; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84899897541     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.11.040     Document Type: Article

References (23)

1. A. Agarwal 5th ed Gass' Atlas of Macular Disease vol. 1 2012 Elsevier Saunders Edinburgh, Scotland 222 224
2. L. Ficker, G. Vafidis, A. While, and P. Leaver Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy Br J Ophthalmol 72 1988 829 834
3. R. Brancato, A. Scialdone, and A. Pece et al. Eight-year follow-up of central serous chorioretinopathy with and without laser treatment Graefes Arch Clin Exp Ophthalmol 225 1987 166 168
4. L.A. Yannuzzi, J.S. Slakter, and N.E. Gross et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study Retina 23 2003 288 298
5. F. Cardillo Piccolino, and C. Eandi et al. Photodynamic therapy for chronic central serous chorioretinopathy Retina 23 2003 752 763
6. Y. Imamura, T. Fujiwara, and R.F. Spaide Fundus autofluorescence and visual acuity in central serous chorioretinopathy Ophthalmology 118 2011 700 705
7. C.M. Eandi, J.E. Chung, F. Cardillo-Piccolino, and R.F. Spaide Optical coherence tomography in unilateral resolved central serous chorioretinopathy Retina 25 2005 417 421
8. S. Ooto, M. Hangai, and A. Sakamoto et al. High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy Ophthalmology 117 2010 1800 1809
9. B.S. Everitt The Cambridge Dictionary of Statistics 3rd ed. 2006 Cambridge University Press Cambridge, UK 67
10. U. Schmidt-Erfurth, J. Miller, and M. Sickenberg et al. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples Graefes Arch Clin Exp Ophthalmol 236 1998 365 374
11. A. Rouvas, P. Stavrakas, and P.G. Theodossiadis et al. Long-term results of half-fluence photodynamic therapy for chronic central serous chorioretinopathy Eur J Ophthalmol 22 2012 417 422
12. M. Reibaldi, N. Cardascia, and A. Longo et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial Am J Ophthalmol 149 2010 307 315
13. E. Smretschnig, S. Ansari-Shahrezaei, and S. Hagen et al. Half-fluence photodynamic therapy in chronic central serous chorioretinopathy Retina 33 2013 316 323
14. R. Uetani, Y. Ito, and K. Oiwa et al. Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy Eye (Lond) 26 2012 640 649
15. S.H. Bae, J.W. Heo, and C. Kim et al. A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy Am J Ophthalmol 152 2011 784 792
16. J.Y. Shin, S.J. Woo, H.G. Yu, and K.H. Park Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy Retina 31 2011 119 126
17. S. Goto, F. Gomi, C. Ueno, and K. Nishida Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability Am J Ophthalmol 154 2012 865 871
18. R.M. Silva, J.M. Ruiz-Moreno, and F. Gomez-Ulla et al. Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study Retina 33 2013 309 315
19. A. Shinojima, A. Kawamura, and R. Mori et al. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy Retina 31 2011 1912 1920
20. I. Maruko, T. Iida, and Y. Sugano et al. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy Ophthalmology 117 2010 1792 1799
21. N.H. Kang, and Y.T. Kim Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy Eye (Lond) 27 2013 387 391
22. F. Semeraro, M.R. Romano, and P. Danzi et al. Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy Jpn J Ophthalmol 56 2012 608 612
23. J.S. Nielsen, and L.M. Jampol Oral mifepristone for chronic central serous chorioretinopathy Retina 31 2011 1928 1936